Aberrant LYZ expression in tumor cells serves as the potential biomarker and target for HCC and promotes tumor progression via csGRP78Zhiwen Gu, Aihua Sun, Kaikun Xu et al.|Proceedings of the National Academy of Sciences|2023Cited by 37